08 Sep 2021

EECP is a non-invasive, US-FDA approved treatment modality which can be used at any age, at any time, by all patients suffering from refractory Angina before or after coronary angioplasty or bypass operation.

  • Patient who are not eligible for Angioplasty or bypass operation
  • Patients who have undergone Angioplasty or bypass opertaion, but there are reblockages  in stents or grafts
  • Patients who are suffering from severe Kidney, Liver or Lung disease and are ineligible for invasive procedures